MLMarc Luy

Marc Luy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marc Luy has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers
    Open Access

    Why do women live longer than men, but spend more time in poor health? A decomposition analysis of the gender gap in unhealthy life years across Europe

    by Magdalena Muszynska-Spielauer, Paola Di Giulio, Yuka Minagawa, Vanessa Di Lego, Marc Luy

    This study tests the “longevity hypothesis,” which posits that women’s greater number of years spent in poor health is primarily a direct consequence of their longer survival. We analyse gender differences in unhealthy life years (ULY) at age 50 across 22 European countries in 2015–2017. ULY was estimated using three approaches—the Sullivan method, the cross-sectional average length of healthy life, and multistate life tables—applied to four health indicators of varying severity: chronic diseases, functional limitations, self-rated health, and disability. Data were drawn from the Human Mortality Database and the Survey of Health, Ageing and Retirement in Europe. We decomposed the gender gap in ULY into a “mortality effect” (ME), reflecting differences in life years lived, and a “health effect” (HE), reflecting differences in morbidity prevalence. Women at age 50 lived more unhealthy years than men across almost all health indicators and countries. In most cases, more than half of the gender gap in ULY was attributable to the ME, indicating that women’s longer survival primarily explains their greater number of years spent in poor health. The HE showed greater variation across indicators and countries. Results were most consistent for chronic diseases and self-rated health, while functional limitations and disability yielded smaller and less consistent differences. Findings support the longevity hypothesis: women’s higher life expectancy is the main driver of their longer lifetime spent in poor health. The variation across health dimensions highlights the importance of distinguishing between them when studying gender inequalities in health.


  • Open Access

    Health Expectancy: Increasingly Used, but Not Well Understood

    by Marc Luy, Paola Di Giulio, Vanessa Di Lego, Patrick Lazarevič, Magdalena Muszyńska-Spielauer, Markus Sauerberg

    Good health is central to human happiness and well-being. It contributes substantially to economic progress, as healthy populations live longer and are more productive. The corresponding public health policies are typically assessed based on a structural indicator for “Health Expectancy” (HE) such as the EU’s “Healthy Life Years” (HLY) or the WHO’s “Health-Adjusted Life Expectancy” (HALE). Unfortunately, HE estimates are extremely sensitive to methodological choices, an issue that is widely overlooked. First, the common practice of measuring population health by the distribution of responses to specific survey questions is ambiguous and not straightforward. Consequently, levels and trends of HE vary significantly depending on the underlying data and health indicators. Moreover, HE estimates are also highly sensitive to technical features, such as the age range and partitioning selected for analysis, as well as the technique chosen to add the health dimension to the life table; an issue that has gone remarkably unrecognized. With the aim of filling this important research gap, the European Research Council (ERC) funded a Consolidator Grant project entitled “Levels and trends of health expectancy: understanding its measurement and estimation sensitivity” (LETHE). This special issue of Comparative Population Studies (CPoS) marks the completion of this project. It contains five articles, each dealing with a specific aspect of HE computation or a concrete empirical application based on HE indicators. This editorial summarizes the insights gained during the LETHE project and aims to make users of HE aware of its methodological sensitivities through illustrative empirical examples. A better understanding of these issues is essential to ensure the indicators’ appropriate usage in research as well as in advising policy makers and public health officials. * This is the Editorial on the Special Issue "Levels and Trends of Health Expectancy: Understanding its Measurement and Estimation Sensitivity".


  • Open Access

    No Socioeconomic Inequalities in Mortality among Catholic Monks: A Quasi-Experiment Providing Evidence for the Fundamental Cause Theory

    by Alina Schmitz, Patrick Lazarevič, Marc Luy

    We propose a novel approach to test the fundamental cause theory (FCT) by analyzing the association between socioeconomic status (SES), as measured by the order titles “brothers” and “padres,” and mortality in 2,421 German Catholic monks born between 1840 and 1959. This quasi-experiment allows us to study the effect of SES on mortality in a population with largely standardized living conditions. Mortality analyses based on Kaplan-Meier product limit estimation show that there were no statistically significant survival differences between the high and lower SES monks. This holds for all birth cohorts, indicating that monastic life offers health protection for monks with a lower SES regardless the disease patterns, causes of death, or main risk factors in a given period. These findings support the FCT: Whereas SES-related differences in mortality are a widely confirmed finding in the general population, a context with largely standardized conditions eliminates the importance of SES-related resources.


  • Open Access

    Cross-Sectional Association Between Life Expectancy and Unhealthy Life Years: Proof of Concept Tests of the CroHaM Hypothesis

    by Marc Luy

    The recently presented CroHaM hypothesis says (1) that longitudinal health domain-specific expansion and compression effects depend primarily on the health domains’ mortality risk and (2) that these effects exist equivalently in the cross-sectional context, affecting differences in healthy life years (HLY) between populations and subpopulations with different levels of life expectancy (LE). We test this hypothesis by analysing the association between LE and unhealthy life years (ULY) at age 50 for a large number of subpopulations. The analyses are carried out for three health domains which are differently related to mortality: poor self-perceived health and strong activity limitation with comparatively high mortality, and chronic morbidity with comparatively low risk of dying. Data on gender- and subpopulation-specific prevalence of these health conditions are taken from the Actual German Health Study 2012 (GEDA). LEs are estimated with the “Longitudinal Survival Method”, using data of the German Life Expectancy Survey. ULY are estimated with the “Sullivan Method”. Differences in ULY between each subpopulation and the total population and between women and men for each subpopulation are decomposed into the effects caused by differences in health (“health effect”) and mortality (“mortality effect”) with the “Nusselder/Looman Method”. The results confirm the CroHaM hypothesis: we find a positive relationship between LE and ULY only for chronic morbidity, whereas this relationship is negative for poor self-perceived health and strong activity limitation. However, when the mortality effect is controlled for, we find a negative relationship between LE and ULY for all three health domains. The practical relevance of these findings is discussed using the example of the so-called “gender paradox” in health and mortality. We conclude that the CroHaM hypothesis may describe an important determinant of life years spent with and without health impairment, and it may help to better understand and interpret trends and differentials in HLY or ULY based on cross-sectional data. * This article belongs to a special issue on “Levels and Trends of Health Expectancy: Understanding its Measurement and Estimation Sensitivity”.


  • Open Access

    Das Geschlechterparadoxon in der gesundheitlich beeinträchtigten Lebenszeit – Ende eines Mythos?

    by Marc Luy

    Zusammenfassung: Hintergrund: Frauen leben länger als Männer, verbringen aber mehr Lebensjahre mit gesundheitlicher Beeinträchtigung. In diesem Beitrag wird untersucht, inwieweit dieses Geschlechterparadoxon durch 2 Faktoren erklärt werden kann: den „Mortalitätseffekt“, der aus der höheren Lebenserwartung der Frauen resultiert, und das „Differential Item Functioning“ (DIF), das Geschlechterunterschiede im Berichtsverhalten bezeichnet.Methoden: Die beeinträchtigte Lebenserwartung im Alter 50 für die Gesundheitsindikatoren Allgemeingesundheit, Einschränkungen und chronische Morbidität wird mit der Sullivan-Methode berechnet. Daten zur Gesundheitsprävalenz stammen aus dem Survey „Gesundheit in Deutschland aktuell“ (GEDA) des Jahres 2012, Daten zur Mortalität aus der „Human Mortality Database“. Die Geschlechterdifferenz in der beeinträchtigten Lebenserwartung wird mittels Dekomposition in den Mortalitäts- und den Gesundheitseffekt zerlegt. Letzterer wird schließlich auf der Grundlage von Vignetten aus der ersten Welle des „Survey of Health, Ageing and Retirement in Europe“ (SHARE) um DIF-Effekte bereinigt.Ergebnisse: Das Geschlechterparadoxon lässt sich für alle 3 betrachteten Gesundheitsindikatoren nicht nur teilweise, sondern vollständig durch Mortalitätseffekt und DIF auflösen. Nach Berücksichtigung dieser beiden Faktoren kehrt sich die Geschlechterdifferenz in der beeinträchtigten Lebenserwartung von höheren Werten für Frauen in höhere Werte für Männer um.Diskussion: Die Ursachen für das Geschlechterparadoxon sind sehr komplex und die Frauen-Männer-Differenzen in gesamter und beeinträchtigter Lebenserwartung gehen nicht unbedingt in widersprüchliche Richtungen. Das Ausmaß der höheren beeinträchtigten Lebenserwartung der Frauen hängt entscheidend vom zugrunde liegenden Gesundheitsindikator ab und wird zum größten Teil durch den Mortalitätseffekt erklärt.


  • Open Access

    Healthy life expectancy: a critical look at the benefits and potential of the demographic health indicator

    by Marc Luy

    Zusammenfassung Die demographische Alterung hat vielfältige gesellschaftliche Konsequenzen, deren Ausmaß wesentlich vom Gesundheitszustand der Bevölkerung abhängt. Um diesen analysieren und bewerten zu können, wurden spezielle Kennziffern entwickelt, die in diesem Beitrag mit dem Überbegriff „gesunde Lebenserwartung“ (GLE) bezeichnet werden. Die Herleitung der GLE ist zwar intuitiv und leicht nachvollziehbar. Allerdings verdeckt eine zu einfache Interpretation die große Komplexität, die der Erweiterung der Sterbetafel um die Gesundheitsdimension innewohnt. Diese macht die GLE im Vergleich zur klassischen Lebenserwartung (LE) extrem empfindlich gegenüber verschiedensten konzeptionellen und methodischen Aspekten. In dem Beitrag wird dies für 3 Aspekte genauer dargestellt: die zugrunde liegende Definition von Gesundheit, die Wahl der Datenquelle als Grundlage für die Schätzung des Gesundheitszustands und das Berichtsverhalten der Survey-Teilnehmer. Dabei zeigt sich, dass die Auswirkung auf die GLE enorm sein kann, was zu erheblichen Verzerrungen bei der Interpretation von Niveaus und Trends, aber auch bei der Analyse von Unterschieden zwischen Bevölkerungen führt. Nichtsdestotrotz ist die Erweiterung der klassischen LE zur GLE eine wichtige Errungenschaft, die nicht aufgegeben werden darf. Deswegen werden in dem Beitrag auch Möglichkeiten diskutiert, wie der GLE-Indikator robuster und zuverlässiger gemacht werden könnte. Bis dies erreicht ist, darf die hohe methodische Sensibilität der GLE aber nicht ignoriert werden, wenn man mit ihr den Gesundheitszustand von Bevölkerungen bewertet und sie als Grundlage für gesundheitspolitische Maßnahmen herangezogen wird.


  • Open Access

    The impact of interpersonal reporting heterogeneity on cross-country differences in Healthy Life Years in Europe

    by Marc Luy, Paola Di Giulio, Yuka Minagawa

    Background: The European Union has used Healthy Life Years (HLY) as an indicator to monitor the health of its aging populations. Scholarly and popular interest in HLY across countries has grown, particularly regarding the ranking of countries. It is important to note that HLY is based on self-assessments of activity limitations, raising the possibility that it might be influenced by differences in health reporting behaviours between populations, a phenomenon known as differential item functioning (DIF). Methods: We estimated DIF-adjusted HLY at age 50 for Belgium, France, Germany, Greece, Italy, the Netherlands, Spain, and Sweden to determine the extent to which differences in HLY might be influenced by reporting heterogeneity across countries. We used anchoring vignettes, taken from the 2004 Survey of Health, Ageing and Retirement in Europe, to estimate DIF-adjusted prevalence rates of activity limitations measured by the Global Activity Limitations Indicator (GALI). The Sullivan method was used to calculate DIF-adjusted HLY. Results: Changes in HLY before and after adjustment ranged from a 1.20-year decrease for men in Italy to a 1.61-year increase for women in Spain. Adjustment for DIF produced changes in the rankings of the countries by HLY, with upward and downward movements of up to three positions. Conclusion: Our results show that DIF is likely to affect HLY estimates, thereby posing a challenge to the validity of comparisons of HLY across European countries. The findings suggest that HLY should be used to monitor population health status within a country, rather than to make comparisons across countries.


  • Open Access

    Well-Being Adjusted Health Expectancy: A New Summary Measure of Population Health

    by Magdalena Muszyńska-Spielauer, Marc Luy

    We propose a new summary measure of population health (SMPH), the well-being-adjusted health expectancy (WAHE). WAHE belongs to a subgroup of health-adjusted life expectancy indicators and gives the number of life years equivalent to full health. WAHE combines health and mortality information into a single indicator with weights that quantify the reduction in well-being associated with decreased health. WAHE's advantage over other SMPHs lies in its ability to differentiate between the consequences of health limitations at various levels of severity and its transparent, simple valuation function. Following the guidelines of a Committee on Summary Measures of Population Health, we discuss WAHE's validity, universality, feasibility sensitivity and ensure its reproducibility. We evaluate WAHE's performance compared to life expectancy, the most commonly used indicators of health expectancy (HE) and disability-adjusted life expectancy (DALE) in an empirical application for 29 European countries. Data on health and well-being are taken from the 2018 EU-SILC, and the life tables are from Eurostat. DALE is taken from the database of the Global Burden of Disease Programme. WAHE's sensitivity to univariate and multivariate state specifications is studied using the three Minimum European Health Module health dimensions: chronic morbidity, limitations in activities of daily living, and self-rated health. The empirical tests of the indicators’ correspondence reveal that WAHE has the strongest correlation with the other SMPHs. Moreover, WAHE estimates are in agreement with all other SMPHs. Additionally, WAHE and all other SMPHs form a group of reliable indicators for studying population health in European countries. Finally, WAHE estimates are robust, regardless of whether health is defined across one or multiple simultaneous dimensions of health. We conclude that WAHE is a useful and reliable indicator of population health and performs at least as well as other commonly used SMPHs.